Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 17.8719.94309.00-25.23-

What is the latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS is 17.87 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202417.87
Mar202319.94
Mar2022309.00
Mar2021-25.23
Mar2020-

How is Core EBITDA Growth of SOTAC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 17.87
-10.38
Mar2023 19.94
-93.55
Mar2022 309
Positive
Mar2021 -25.23
0
Mar2020 0 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹121.5 Cr -1.1% -20% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-1.1%

-20%

-8.1%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses